Paper Details
- Home
- Paper Details
Localized alopecia and suppression of hypothalamic-pituitary-adrenal (HPA) axis in dogs following treatment with difluprednate 0.05% ophthalmic emulsion (Durezol®).
Author: AndersonAmanda L, BurnJessica B, Del ValleJacquelyn M, HarmanChristine D, KomáromyAndrás M, LangloisDaniel K, NolandErica L, OccelliLaurence M, PetersenAnnette D, Petersen-JonesSimon M, PirieChris G, QuantzKatelin
Original Abstract of the Article :
BACKGROUND: Despite the common use of topical ophthalmic corticosteroids in dogs, detailed reports on systemic and dermatologic adverse effects are limited. RESULTS: Nine purpose-bred research Beagles were treated with difluprednate 0.05% ophthalmic emulsion in one or both eyes 2-3 times daily. Som...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638448/
データ提供:米国国立医学図書館(NLM)
The Impact of Difluprednate Ophthalmic Emulsion on Dogs
The field of veterinary ophthalmology is always striving to improve the well-being of our furry friends. This research delves into the effects of difluprednate ophthalmic emulsion, a commonly used corticosteroid for dogs. The study used a group of Beagles to investigate the potential systemic and dermatological side effects associated with long-term use of this medication. The researchers discovered that prolonged use of difluprednate can suppress the hypothalamic-pituitary-adrenal (HPA) axis, which is the body's natural stress response system. This suppression can lead to a condition called iatrogenic hyperadrenocorticism, essentially meaning the dog's body is being tricked into thinking it's constantly stressed.
Localized Alopecia: A Unique Side Effect
The research further identified a novel pattern of localized alopecia, or hair loss, in the dogs treated with difluprednate. This pattern is characterized by hair loss around the eyes, face, and ears. The researchers believe this alopecia is likely caused by the absorption of difluprednate through the skin and its localized effects.
Health Considerations and Lifestyle Changes
These findings highlight the importance of carefully monitoring dogs treated with difluprednate for signs of HPA axis suppression and alopecia. If you notice hair loss or other unusual changes in your dog, it is crucial to consult with your veterinarian. Just like we need to be mindful of our own long-term medication use, we must be attentive to the potential side effects of medications given to our animal companions.
Dr. Camel's Conclusion
Difluprednate ophthalmic emulsion, while effective in treating certain eye conditions, can have unintended consequences. Just like a camel navigating a desert landscape, we need to be aware of the potential risks and benefits before embarking on a journey of long-term medication use for our beloved pets. This study sheds light on the importance of continued research in veterinary ophthalmology to ensure the best possible care for our animal companions.
Date :
- Date Completed 2022-03-03
- Date Revised 2022-03-03
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.